Collaborative Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,933
Closed -$313K 181
2024
Q3
$313K Hold
1,933
0.14% 125
2024
Q2
$283K Sell
1,933
-147
-7% -$21.9K 0.14% 128
2024
Q1
$329K Sell
2,080
-9
-0.4% -$1.43K 0.17% 114
2023
Q4
$328K Sell
2,089
-399
-16% -$61.2K 0.18% 111
2023
Q3
$387K Buy
2,488
+157
+7% +$25.9K 0.23% 100
2023
Q2
$386K Buy
2,331
+35
+2% +$5.65K 0.23% 99
2023
Q1
$356K Sell
2,296
-1
-0% -$161 0.22% 110
2022
Q4
$406K Hold
2,297
0.27% 99
2022
Q3
$375K Hold
2,297
0.27% 100
2022
Q2
$408K Buy
+2,297
New +$409K 0.27% 106
2021
Q4
$444K Buy
+2,594
New +$425K 0.24% 123
2021
Q1
$407K Buy
+2,297
New +$372K 0.23% 128

Other funds holding JNJ

Collaborative Wealth Management's JNJ Position: Q4 2024 in Review

Collaborative Wealth Management sold out of Johnson & Johnson (JNJ) in Q4 2024, closing a stake of 1,933 shares — an estimated $313K sold.

Collaborative Wealth Management first reported a position in JNJ in Q1 2021 and held it in 12 quarters. The position peaked at $444K in Q4 2021. 4,104 funds tracked by Wall St. Rank hold JNJ as of Q4 2024.

  • Collaborative Wealth Management reported no remaining Johnson & Johnson position as of Q4 2024 after selling out during the quarter.
  • Collaborative Wealth Management sold 1,933 Johnson & Johnson shares in Q4 2024, an estimated $313K.
  • Collaborative Wealth Management first reported a position in Johnson & Johnson in Q1 2021 and held it in 12 quarters.
  • Collaborative Wealth Management's Johnson & Johnson position peaked at $444K in Q4 2021.
  • 4,104 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2024.

Based on Collaborative Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.